Journal article
Population-Based Study of Risk of AKI with Levetiracetam
Abstract
BACKGROUND AND OBJECTIVES: Regulatory agencies warn about the risk of AKI with levetiracetam use on the basis of information from case reports. We conducted this study to determine whether new levetiracetam use versus nonuse is associated with a higher risk of AKI.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a population-based retrospective cohort study of adults with epilepsy in Ontario, Canada. Patients who received a new …
Authors
Yau K; Burneo JG; Jandoc R; McArthur E; Muanda FT; Parikh CR; Wald R; Weir MA; Garg AX
Journal
Clinical Journal of the American Society of Nephrology, Vol. 14, No. 1, pp. 17–26
Publisher
Wolters Kluwer
Publication Date
January 2019
DOI
10.2215/cjn.07490618
ISSN
1555-9041
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Acute Kidney InjuryAdultAgedAged, 80 and overAnticonvulsantsCreatinineEmergency Service, HospitalFemaleHumansLevetiracetamMembrane GlycoproteinsMiddle AgedNephritis, InterstitialNephrologyPatient AdmissionReceptors, Interleukin-1Referral and ConsultationRetrospective StudiesRhabdomyolysisRisk FactorsTime Factors